The federal government’s 340B program is designed to promote access to affordable medications for the most vulnerable or underserved patient populations, while helping to stretch government resources. This program mandates that drug manufacturers provide outpatient drugs at greatly discounted prices to qualifying hospitals and healthcare organizations.
Avella partners with these organizations to help manage their 340B programs and mitigate risks. This includes providing policies and procedures to:
- Verify patient eligibility.
- Prevent duplicate discounts for Medicaid-eligible prescriptions.
- Store data needed for audits with regard to purchases, patient eligibility, prescription records and billing.
Fill in your contact information to learn more about the 340B program, and how Avella collaborates with 340B-qualifying organizations throughout the U.S.